Tactile Systems Technology Q3 Revenue Grows 7% Amid Rising Expenses and Airway Clearance Slump
Tactile Systems Technology (TCMD) reported third-quarter revenue of $91.9 million, a 7% increase year-over-year, driven by double-digit growth in its core lymphedema business. However, net income declined to $7.2 million from $8.2 million as sales and administrative expenses outpaced revenue gains. The company's airway clearance segment saw a significant 25% revenue drop, which management attributed to inventory transitions following the launch of a new AffloVest model. Despite the earnings miss causing an 8% drop in after-hours trading, management maintained its 2026 revenue outlook and slightly raised its adjusted EBITDA forecast. Investors remain focused on whether the company can stabilize operating expenses and if airway clearance sales will rebound in the fourth quarter as suppliers restock new inventory.
Coverage
- TACTILE SYSTEMS TECHNOLOGY INC - 10-Q Filing
- TACTILE SYSTEMS TECHNOLOGY INC - 10-Q Filing
- Tactile Systems Technology Q3 Revenue Grows 7% Amid Rising Expenses and Airway Clearance Slump
- UDR FFO of $0.65 beats by $0.01, revenue of $428.08M in-line
- CRISPR Therapeutics AG - 10-Q Filing
- Realty Income FFO of $1.10 in-line, revenue of $1.62B beats by $170M
- VICI Properties Reports Q3 Revenue Beat Amid Rising Expenses